Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 4Breast 2CNS 1

Conditions

Breast Neoplasms 13132Triple Negative Breast Neoplasms 1149Neoplasms 749Ovarian Neoplasms 680Neoplasm Metastasis 590Lung Neoplasms 582Colorectal Neoplasms 580Prostatic Neoplasms 560Carcinoma, Non-Small-Cell Lung 535Pancreatic Neoplasms 380Melanoma 366Stomach Neoplasms 350Colonic Neoplasms 330Motor Activity 285Breast Neoplasms, Male 285Carcinoma, Intraductal, Noninfiltrating 277Uterine Cervical Neoplasms 267Head and Neck Neoplasms 266Endometrial Neoplasms 256Carcinoma, Renal Cell 216Sarcoma 203Urinary Bladder Neoplasms 192Squamous Cell Carcinoma of Head and Neck 192Lymphedema 190Esophageal Neoplasms 189Breast Carcinoma In Situ 189Brain Neoplasms 183Fatigue 166Carcinoma, Ovarian Epithelial 151Small Cell Lung Carcinoma 148

Interventions

Vernalization 1Epirubicin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Kenny-Caffey syndrome, Type 1 × Breast × Clear all
NCT07156253 2025-09-05

Study of SYN818 With Olaparib for the Treatment of Locally Advanced or Metastatic Solid Tumors

Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd

Phase 1 Recruiting
110 enrolled
BreastGynecologic

Kenny-Caffey syndrome, Type 1, Breast Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms

NCT02789332 2020-03-17

GeparOla

GBG Forschungs GmbH

Phase 2 Completed
107 enrolled
Breast

Kenny-Caffey syndrome, Type 1, Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡